Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 2
1968 1
1969 6
1970 6
1971 7
1972 6
1973 2
1974 3
1975 3
1977 3
1978 1
1979 2
1980 3
1982 3
1983 4
1984 4
1985 1
1986 4
1987 3
1988 3
1989 5
1990 8
1991 2
1992 2
1994 5
1995 1
1996 2
1997 2
1998 1
1999 3
2000 5
2001 5
2002 5
2003 9
2004 10
2005 6
2006 9
2007 10
2008 5
2009 12
2010 10
2011 6
2012 9
2013 16
2014 13
2015 11
2016 19
2017 16
2018 22
2019 22
2020 12
2021 10
2022 1
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial.
Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, Hernandez AF, Braunwald E; National Heart Lung and Blood Institute Heart Failure Clinical Research Network. Butler J, et al. JAMA Cardiol. 2017 Sep 1;2(9):950-958. doi: 10.1001/jamacardio.2017.2198. JAMA Cardiol. 2017. PMID: 28700781 Free PMC article. Clinical Trial.
Hyperaldosteronism.
Tidd MJ. Tidd MJ. Br Med J. 1969 Oct 4;4(5674):52-3. doi: 10.1136/bmj.4.5674.52-c. Br Med J. 1969. PMID: 5822099 Free PMC article. No abstract available.
Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trial.
Faconti L, Mills CE, Govoni V, Gu H, Morant S, Jiang B, Cruickshank JK, Webb AJ. Faconti L, et al. Br J Clin Pharmacol. 2019 Jan;85(1):169-180. doi: 10.1111/bcp.13783. Epub 2018 Nov 13. Br J Clin Pharmacol. 2019. PMID: 30294825 Free PMC article. Clinical Trial.
311 results